Trilaciclib significantly reduced chemotherapy-induced myelosuppression in extensive-stage small cell lung cancer, which ...

A doctor at a local cancer institute hopes to do more clinical studies to see if lab findings apply to actual patients. Read more at straitstimes.com.

The following is a summary of “Clinical significance and pro-oncogenic function of DBF4 in clear cell renal cell carcinoma,” published in the January 2025 issue of Urology by Chen et al. Clear cell ...

Financially, UroGen has a market cap of $464mn and a cash runway of 8-9 quarters, despite facing patent challenges from Teva.

A common aromatic shrub that has served as traditional medicine for centuries could point the way toward innovative treatments for colorectal cancer ...

Results of 3 trials revealed that omitting transplant did not impact progression or survival outcomes for pediatric, ...

Nicola Francis has had 20 operations since being born after she was diagnosed with a rare and aggressive tumour after falling ...

Sintilimab plus neoadjuvant CRT improved pathological complete response rates in resectable, locally advanced ESCC, per phase ...

The expanding oncology pipeline in the USA is a key driver for cytotoxic drug demand, with over 1,000 oncology drugs in development. Advancements in ...

New research shows persistent DNA lesions in stem cells contribute to mutations, with links to blood cancers and external ...

THIS boy was given a second chance at life by his sister, who fought through sepsis to help him survive. Three-year-old James ...